Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Biol. Chem. 278 (46): 45485-45491

© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

Convergence of Peroxisome Proliferator-activated Receptor {gamma} and Foxo1 Signaling Pathways*

Paul Dowell{ddagger}§, Tamara C. Otto{ddagger}, Saleh Adi¶, , and M. Daniel Lane{ddagger}

{ddagger}Biological Chemistry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Abstract: The forkhead factor Foxo1 (or FKHR) was identified in a yeast two-hybrid screen as a peroxisome proliferator-activated receptor (PPAR) {gamma}-interacting protein. Foxo1 antagonized PPAR{gamma} activity and vice versa indicating that these transcription factors functionally interact in a reciprocal antagonistic manner. One mechanism by which Foxo1 antagonizes PPAR{gamma} activity is through disruption of DNA binding as Foxo1 inhibited the DNA binding activity of a PPAR{gamma}/retinoid X receptor {alpha} heterodimeric complex. The Caenorhabditis elegans nuclear hormone receptor, DAF-12, interacted with the C. elegans forkhead factor, DAF-16, paralleling the interaction between PPAR{gamma} and Foxo1. daf-12 and daf-16 have been implicated in C. elegans insulin-like signaling pathways, and PPAR{gamma} and Foxo1 likewise have been linked to mammalian insulin signaling pathways. These results suggest a convergence of PPAR{gamma} and Foxo1 signaling that may play a role in insulin action and the insulinomimetic properties of PPAR{gamma} ligands. A more general convergence of nuclear hormone receptor and forkhead factor pathways may be important for multiple biological processes and this convergence may be evolutionarily conserved.


Received for publication August 15, 2003.

* This work was supported by Grants DK09894 and DK64934 (to P. D.) and DK38418 (to M. D. L.) from NIDDK, National Institutes of Health and by an Institutional Research Grant from Johns Hopkins University (to S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Biological Chemistry, WBSB 509, 725 N. Wolfe St., Baltimore, MD 21205. Tel.: 410-955-3975; Fax: 410-955-0903; E-mail: dowellp{at}jhmi.edu.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
MicroRNA-146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade.
J. Ahn, H. Lee, C. H. Jung, T. I. Jeon, and T. Y. Ha (2013)
EMBO Mol Med. 5, 1602-1612
   Abstract »    Full Text »    PDF »
A comparative perspective on lipid storage in animals.
K. Birsoy, W. T. Festuccia, and M. Laplante (2013)
J. Cell Sci. 126, 1541-1552
   Abstract »    Full Text »    PDF »
Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy.
V. Resi, S. Basu, M. Haghiac, L. Presley, J. Minium, B. Kaufman, S. Bernard, P. Catalano, and S. Hauguel-de Mouzon (2012)
Am J Physiol Endocrinol Metab 303, E832-E840
   Abstract »    Full Text »    PDF »
FoxO1 Inhibits Sterol Regulatory Element-binding Protein-1c (SREBP-1c) Gene Expression via Transcription Factors Sp1 and SREBP-1c.
X. Deng, W. Zhang, I. O-Sullivan, J. B. Williams, Q. Dong, E. A. Park, R. Raghow, T. G. Unterman, and M. B. Elam (2012)
J. Biol. Chem. 287, 20132-20143
   Abstract »    Full Text »    PDF »
Putting the brakes on FOXO1 in fat.
J. J. Kim, W. Fan, and J. M. Olefsky (2012)
EMBO J. 31, 2240-2241
   Abstract »    Full Text »    PDF »
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
J. Nakae, Y. Cao, F. Hakuno, H. Takemori, Y. Kawano, R. Sekioka, T. Abe, H. Kiyonari, T. Tanaka, J. Sakai, et al. (2012)
EMBO J. 31, 2275-2295
   Abstract »    Full Text »    PDF »
Nuclear FoxO1 inflames insulin resistance.
J. E. Dominy and P. Puigserver (2010)
EMBO J. 29, 4068-4069
   Abstract »    Full Text »    PDF »
FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.
W. Fan, H. Morinaga, J. J. Kim, E. Bae, N. J. Spann, S. Heinz, C. K. Glass, and J. M. Olefsky (2010)
EMBO J. 29, 4223-4236
   Abstract »    Full Text »    PDF »
Survival strategies of a sterol auxotroph.
M. Carvalho, D. Schwudke, J. L. Sampaio, W. Palm, I. Riezman, G. Dey, G. D. Gupta, S. Mayor, H. Riezman, A. Shevchenko, et al. (2010)
Development 137, 3675-3685
   Abstract »    Full Text »    PDF »
Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor {gamma} Agonists: Requirement for mTOR/Akt2 in PPAR{gamma} Activation.
A. V. Finn, M. John, G. Nakazawa, R. Polavarapu, V. Karmali, X. Xu, Q. Cheng, T. Davis, C. Raghunathan, E. Acampado, et al. (2009)
Circ. Res. 105, 1003-1012
   Abstract »    Full Text »    PDF »
Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-{gamma} Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton.
M. Almeida, E. Ambrogini, L. Han, S. C. Manolagas, and R. L. Jilka (2009)
J. Biol. Chem. 284, 27438-27448
   Abstract »    Full Text »    PDF »
FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor {gamma} Activation in Adipose Tissue.
J. J. Kim, P. Li, J. Huntley, J. P. Chang, K. C. Arden, and J. M. Olefsky (2009)
Diabetes 58, 1275-1282
   Abstract »    Full Text »    PDF »
FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor {gamma} Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes.
W. Fan, T. Imamura, N. Sonoda, D. D. Sears, D. Patsouris, J. J. Kim, and J. M. Olefsky (2009)
J. Biol. Chem. 284, 12188-12197
   Abstract »    Full Text »    PDF »
A PGC-1{alpha}-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose.
M. P. Housley, N. D. Udeshi, J. T. Rodgers, J. Shabanowitz, P. Puigserver, D. F. Hunt, and G. W. Hart (2009)
J. Biol. Chem. 284, 5148-5157
   Abstract »    Full Text »    PDF »
SIRT2 Suppresses Adipocyte Differentiation by Deacetylating FOXO1 and Enhancing FOXO1's Repressive Interaction with PPAR{gamma}.
F. Wang and Q. Tong (2009)
Mol. Biol. Cell 20, 801-808
   Abstract »    Full Text »    PDF »
O-GlcNAc Regulates FoxO Activation in Response to Glucose.
M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, and G. W. Hart (2008)
J. Biol. Chem. 283, 16283-16292
   Abstract »    Full Text »    PDF »
The emerging role of FOXO transcription factors in pancreatic {beta} cells.
D. A Glauser and W. Schlegel (2007)
J. Endocrinol. 193, 195-207
   Abstract »    Full Text »    PDF »
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.
S. Qu, D. Su, J. Altomonte, A. Kamagate, J. He, G. Perdomo, T. Tse, Y. Jiang, and H. H. Dong (2007)
Am J Physiol Endocrinol Metab 292, E421-E434
   Abstract »    Full Text »    PDF »
Insulin Regulation of Skeletal Muscle PDK4 mRNA Expression Is Impaired in Acute Insulin-Resistant States..
Y. I. Kim, F. N. Lee, W. S. Choi, S. Lee, and J. H. Youn (2006)
Diabetes 55, 2311-2317
   Abstract »    Full Text »    PDF »
FOXO1 Represses Peroxisome Proliferator-activated Receptor-{gamma}1 and -{gamma}2 Gene Promoters in Primary Adipocytes: A NOVEL PARADIGM TO INCREASE INSULIN SENSITIVITY.
M. Armoni, C. Harel, S. Karni, H. Chen, F. Bar-Yoseph, M. R. Ver, M. J. Quon, and E. Karnieli (2006)
J. Biol. Chem. 281, 19881-19891
   Abstract »    Full Text »    PDF »
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action..
V. T. Samuel, C. S. Choi, T. G. Phillips, A. J. Romanelli, J. G. Geisler, S. Bhanot, R. McKay, B. Monia, J. R. Shutter, R. A. Lindberg, et al. (2006)
Diabetes 55, 2042-2050
   Abstract »    Full Text »    PDF »
FoxO1 Regulates Multiple Metabolic Pathways in the Liver: EFFECTS ON GLUCONEOGENIC, GLYCOLYTIC, AND LIPOGENIC GENE EXPRESSION.
W. Zhang, S. Patil, B. Chauhan, S. Guo, D. R. Powell, J. Le, A. Klotsas, R. Matika, X. Xiao, R. Franks, et al. (2006)
J. Biol. Chem. 281, 10105-10117
   Abstract »    Full Text »    PDF »
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity.
J. C. Corton and H. M. Brown-Borg (2005)
J Gerontol A Biol Sci Med Sci 60, 1494-1509
   Abstract »    Full Text »    PDF »
Balancing protein similarity and gene co-expression reveals new links between genetic conservation and developmental diversity in invertebrates.
C. Lefebvre, J.-C. Aude, E. Glemet, and C. Neri (2005)
Bioinformatics 21, 1550-1558
   Abstract »    Full Text »    PDF »
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Y. Yang, H. Hou, E. M. Haller, S. V. Nicosia, and W. Bai (2005)
EMBO J. 24, 1021-1032
   Abstract »    Full Text »    PDF »
Nuclear Hormone Receptors, Metabolism, and Aging: What Goes Around Comes Around.
K. Pardee, J. Reinking, and H. Krause (2004)
Sci. Aging Knowl. Environ. 2004, re8
   Abstract »    Full Text »    PDF »
Regulation of Peroxisome Proliferator-Activated Receptor-{gamma} Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis.
J. E. Kim and J. Chen (2004)
Diabetes 53, 2748-2756
   Abstract »    Full Text »    PDF »
Identification of C. elegans DAF-12-binding sites, response elements, and target genes.
Y. Shostak, M. R. Van Gilst, A. Antebi, and K. R. Yamamoto (2004)
Genes & Dev. 18, 2529-2544
   Abstract »    Full Text »    PDF »
The Forkhead Transcription Factor FoxC2 Inhibits White Adipocyte Differentiation.
K. E. Davis, M. Moldes, and S. R. Farmer (2004)
J. Biol. Chem. 279, 42453-42461
   Abstract »    Full Text »    PDF »
Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control.
Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, H. Aburatani, et al. (2004)
J. Biol. Chem. 279, 41114-41123
   Abstract »    Full Text »    PDF »
Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes.
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto (2004)
Mol. Cell. Biol. 24, 7931-7940
   Abstract »    Full Text »    PDF »
A novel nuclear receptor/coregulator complex controls C. elegans lipid metabolism, larval development, and aging.
A. H. Ludewig, C. Kober-Eisermann, C. Weitzel, A. Bethke, K. Neubert, B. Gerisch, H. Hutter, and A. Antebi (2004)
Genes & Dev. 18, 2120-2133
   Abstract »    Full Text »    PDF »
Protein Kinase B/AKT 1 Plays a Pivotal Role in Insulin-like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation.
J. Xu and K. Liao (2004)
J. Biol. Chem. 279, 35914-35922
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882